SCHEMBL6284658

SCHEMBL6284658

Nc1cccc([N+](=O)[O-])c1OCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.50
ADRA1D P25100 1/20 0.50
ADRA1A P35348 1/20 0.50
ADRA1B P35368 1/20 0.50
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
ATM Q13315 1/20 0.48
PIN1 Q13526 2/20 0.47
MGMT P16455 1/20 0.47
RECQL P46063 1/20 0.46
AR P10275 1/20 0.45
SGMS2 Q8NHU3 1/20 0.44
KDM4E B2RXH2 1/20 0.44
POLB P06746 3/20 0.43
PDE7A Q13946 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CTSV O60911 1/20 0.43
CTSL P07711 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3092379 0.98 HTR1A (0.49) HTR1AADRA1DADRA1AADRA1BMEN1
SCHEMBL27388637 0.89 HTR1A (0.55) HTR1AADRA1DADRA1AADRA1BMEN1
SCHEMBL11549296 0.82 NPC1 (0.58) HTR1AADRA1DADRA1AADRA1BMEN1
SCHEMBL11546681 0.82 RECQL (0.49) MEN1KMT2ANPC1RAB9ARECQL
SCHEMBL4928212 0.82 MAPT (0.55) HTR1AADRA1DADRA1AADRA1BMEN1
SCHEMBL31415056 0.82 HTR1A (0.50) HTR1AADRA1DADRA1AADRA1BMEN1
SCHEMBL1180288 0.82 HTR1A (0.50) HTR1AADRA1DADRA1AADRA1BMEN1
SCHEMBL544946 0.82 HTR1A (0.50) HTR1AADRA1DADRA1AADRA1BMEN1
SCHEMBL3088462 0.82 HTR1A (0.50) HTR1AADRA1DADRA1AADRA1BMEN1
SCHEMBL15871971 0.82 HTR1A (0.53) HTR1AADRA1DADRA1AADRA1BMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170095475-A1 HETEROARYL COMPOUNDS AND USES THEREOF CELGENE CAR LLC (BM) 2017-04-06 US disclosed
US-9549927-B2 Heteroaryl compounds and uses thereof CELGENE AVILOMICS RESEARCH, INC. (US) 2017-01-24 US disclosed
US-9415049-B2 Heteroaryl compounds and uses thereof CELGENE AVILOMICS RESEARCH, INC. (US) 2016-08-16 US disclosed
US-20150374690-A1 HETEROARYL COMPOUNDS AND USES THEREOF CELGENE CAR LLC (BM) 2015-12-31 US disclosed
EP-2935226-A1 HETEROARYL COMPOUNDS AND USES THEREOF Celgene Avilomics Research, Inc. (US) 2015-10-28 EP disclosed
US-9126950-B2 Heteroaryl compounds and uses thereof CELGENE AVILOMICS RESEARCH, INC. (US) 2015-09-08 US disclosed
US-20150174128-A1 HETEROARYL COMPOUNDS AND USES THEREOF CELGENE AVILOMICS RESEARCH, INC. (US) 2015-06-25 US disclosed
WO-2014100748-A1 HETEROARYL COMPOUNDS AND USES THEREOF CELGENE AVILOMICS RESEARCH, INC. (US) 2014-06-26 WO disclosed
US-20140179720-A1 HETEROARYL COMPOUNDS AND USES THEREOF CELGENE AVILOMICS RESEARCH, INC. (US) 2014-06-26 US disclosed
US-6969711-B2 Cyclic diamine compounds and medicine containing the same KOWA COMPANY, LTD. (JP) 2005-11-29 US disclosed
EP-0987254-B1 NOVEL CYCLIC DIAMINE COMPOUNDS AND MEDICINE CONTAINING THE SAME KOWA CO (JP) 2004-12-22 EP disclosed
US-20040038987-A1 Novel cyclic diamine compounds and medicine containing the same KOWA COMPANY, LTD. (JP) 2004-02-26 US disclosed
EP-0987254-A1 NOVEL CYCLIC DIAMINE COMPOUNDS AND MEDICINE CONTAINING THE SAME Kowa Co., Ltd. (JP) 2000-03-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150374690-A1 HETEROARYL COMPOUNDS AND USES THEREOF ABCG2, CYP3A43, CYP3A5 HTR1A 921/4885ADRA1D 1406/4885ADRA1A 1188/4885
US-20150174128-A1 HETEROARYL COMPOUNDS AND USES THEREOF ABCG2, CYP3A43, CYP3A5 HTR1A 921/4885ADRA1D 1406/4885ADRA1A 1188/4885
US-20170095475-A1 HETEROARYL COMPOUNDS AND USES THEREOF ABCG2, CYP3A43, CYP3A5 HTR1A 921/4885ADRA1D 1406/4885ADRA1A 1188/4885
US-20040038987-A1 Novel cyclic diamine compounds and medicine containing the same LCAT, ACAT2, ACAT1 HTR1A 3956/4885ADRA1D 623/4885ADRA1A 781/4885
US-20140179720-A1 HETEROARYL COMPOUNDS AND USES THEREOF ABCG2, CYP3A43, CYP3A5 HTR1A 921/4885ADRA1D 1406/4885ADRA1A 1188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.